WeVote

Bill

Bill

HB 752

AN ACT relating to blood donation.

2026 Regular Session Introduced by Josh Calloway and 1 co-sponsor

HB 752 aims to regulate Kentucky blood donation standards for collection, testing, handling, storage, and donor eligibility to ensure safety and compliance.

to Health Services (H)
0
WeVote Research Nonpartisan
Bill Summary · HB 752

Purpose and intent

HB 752 from the 2026 Regular Session of Kentucky (2026RS) titled “AN ACT relating to blood donation” is designed to address policies, procedures, and practices surrounding blood donation within the state. The bill’s overarching aim appears to be to regulate, promote, or optimize the collection and use of blood donations, with potential implications for healthcare providers, blood banks, donors, and recipients.

Key provisions and changes (as available)

  • The bill is currently in the Health Services (H) Committee after introduction in the House on February 25, 2026, and referral to the Committee on Committees the same day. The action history indicates initial steps toward consideration, but the text of the bill’s substantive provisions is not provided here.
  • Based on the title, the bill likely addresses one or more of the following areas commonly included in blood donation legislation (note: these are inferred possibilities and should be verified against the bill’s actual text):
    • Standards for blood collection, handling, testing, and storage.
    • Requirements or guidelines for donor eligibility and screening.
    • Informed consent and donor privacy protections.
    • Allocation, distribution, or reporting requirements for blood products.
    • Coordination with state public health agencies, hospitals, or licensed blood centers.
    • Public health reporting, data collection, or transparency related to blood donation activities.
  • No dollar amounts, funding provisions, or specific regulatory mechanisms are provided in the available information.

Who or what would be affected

  • Blood banks, blood centers, and hospitals involved in blood collection, processing, testing, storage, and distribution.
  • Blood donors and prospective donors, including any eligibility criteria, consent processes, or privacy protections.
  • Healthcare providers and facilities that rely on blood products for patient care.
  • State and local public health agencies responsible for oversight, reporting, and compliance with blood donation standards.

Procedural and timeline aspects

  • Introduction: February 25, 2026.
  • Referral: February 25, 2026 (to Committee on Committees) and subsequently to the Health Services (H) Committee.
  • Current status: Awaiting consideration in the Health Services Committee, per the action history; no floor action or final disposition reported.
  • Next steps typically include committee hearings, potential amendments, votes in the House, and eventual passage or defeat, followed by Senate action and signing if enacted. Specific timelines would follow the committee schedule and legislative deadlines for the 2026RS session.

Notes and next steps for readers

  • To fully understand the bill’s impact, obtain the full text of HB 752 and any fiscal notes, committee statements, or sponsor testimony.
  • Pay attention to any defined terms (e.g., “blood donor,” “blood product,” “collected,” “screening tests”) and any requirements phased in by date.
  • Watch for amendments that could broaden or narrow donor eligibility, impose reporting requirements, or create new regulatory obligations for blood centers.

If you’d like, I can update this summary once the bill’s text and committee amendments become available, or compare it to existing Kentucky blood donation statutes to highlight changes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.